GAITHERSBURG, Md., Jan. 09, 2024 Emergent BioSolutions , a global company providing solutions that address public health threats and brings lifesaving, life-extending products to market, today.
GAITHERSBURG, Md., Jan. 09, 2024 (GLOBE NEWSWIRE) Emergent BioSolutions (NYSE: EBS), a global company providing solutions that address public health threats and brings lifesaving, life-extending products to market, today
Operator: Good afternoon, everyone. I am the operator for today’s call. Thank you for joining today as Emergent discusses the Operational and Financial Results for the Third Quarter of 2023.